Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01431053 | Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer | unknown | Phase 2 | 160 | Chinese Academy of Medical SciencesOTHER | 1 | Mar 13, 2013 | clinicaltrials |
| NCT01038908 | Breast Lymph Node Mapping | unknown | Phase 2 | 100 | University of British ColumbiaOTHER | 1 | Feb 15, 2013 | clinicaltrials |
| NCT00777673 |
| Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery. |
| unknown |
| Phase 2 |
| 60 |
| University of Tennessee Cancer InstituteOTHER |
| 1 |
| Jan 4, 2013 |
| clinicaltrials |
| NCT01732276 | The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer | unknown | Phase 2 | 50 | Jiangmen Central HospitalOTHER | 0 | Dec 3, 2012 | clinicaltrials |
| NCT01625429 | Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast Cancer | unknown | Phase 2 | 30 | Shanghai Cancer Hospital, ChinaOTHER | 1 | Nov 9, 2012 | clinicaltrials |
| NCT01359501 | Evaluation of the Effects of Chinese Medical Treatment on Leucopenia After Chemotherapy in Breast Cancer Patients | unknown | Phase 2 | 100 | China Medical University HospitalOTHER | 1 | Oct 23, 2012 | clinicaltrials |
| NCT00466102 | Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases(RADAR) | unknown | Phase 2 | 130 | GBG Forschungs GmbHOTHER | 1 | Aug 30, 2012 | clinicaltrials |
| NCT01428414 | Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer | unknown | Phase 2 | 100 | Zhimin ShaoOTHER | 1 | Aug 23, 2012 | clinicaltrials |
| NCT01662128 | Efficacy and Safety Of Xeloda as Sequential Adjuvant Therapy After Chemotherapy in Breast Cancer | unknown | Phase 2 / Phase 3 | 600 | Tianjin Medical UniversityOTHER | 1 | Aug 10, 2012 | clinicaltrials |
| NCT01648608 | Efficacy and Safety of TAC and Exemestane as Neoadjuvant Chemotherapy in the Postmenopausal Women With Breast Cancer | unknown | Phase 2 / Phase 3 | 600 | Tianjin Medical UniversityOTHER | 1 | Aug 3, 2012 | clinicaltrials |
| NCT01654367 | Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer(esozao) | unknown | Phase 2 / Phase 3 | 300 | Tianjin Medical UniversityOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT01647672 | Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast Cancer | unknown | Phase 2 / Phase 3 | 60 | Tianjin Medical UniversityOTHER | 1 | Jul 25, 2012 | clinicaltrials |
| NCT01221870 | Tesetaxel as First-line Therapy for Metastatic Breast Cancer | unknown | Phase 2 | 81 | Genta IncorporatedINDUSTRY | 1 | Jul 24, 2012 | clinicaltrials |
| NCT01231802 | Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer | unknown | Phase 2 | 140 | Adherex Technologies, Inc.INDUSTRY | 2 | Jul 17, 2012 | clinicaltrials |
| NCT01641406 | "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"(NACprotocol) | unknown | Phase 2 | 60 | Auxilio Mutuo Cancer CenterOTHER | 1 | Jul 16, 2012 | clinicaltrials |
| NCT00830544 | Study of Neoadjuvant Chemotherapy of Breast Cancer(Neoadjuvant) | unknown | Phase 2 | 54 | Auxilio Mutuo Cancer CenterOTHER | 1 | Jul 13, 2012 | clinicaltrials |
| NCT01609127 | Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer | unknown | Phase 2 | 213 | Genta IncorporatedINDUSTRY | 1 | Jun 1, 2012 | clinicaltrials |
| NCT01088893 | Everolimus in Breast Cancer Patients After Pre-operative Chemotherapy | unknown | Phase 2 | 50 | Organisation for Oncology and Translational ResearchOTHER | 1 | May 24, 2012 | clinicaltrials |
| NCT00721747 | Taxotere®, Followed by Myocet® and Cyclophosphamide First Line Treatment in HER2 Neg Breast Cancer | unknown | Phase 2 | 83 | Grupo Oncológico GallegoOTHER | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00907959 | A Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer | unknown | Phase 2 | 80 | BionovoINDUSTRY | 1 | Feb 8, 2012 | clinicaltrials |
| NCT01528826 | Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective Trial(NVBOX) | unknown | Phase 2 | 35 | Fudan UniversityOTHER | 1 | Feb 8, 2012 | clinicaltrials |
| NCT01526499 | Docetaxel With or Without Metronomic Cyclophosphamide as First Line Chemotherapy in Metastatic Breast Cancer | unknown | Phase 2 | 60 | Fudan UniversityOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT01526512 | Low Dose of Metronomic Cyclophosphamide and Capecitabine in Pretreated HER2-negative Metastatic Breast Cancer | unknown | Phase 2 | 72 | Fudan UniversityOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT01483300 | Effectiveness and Toxicity of Gemcitabine/Lobaplatin Versus Gemcitabine/Cisplatin as Second-line Treatment in Metastatic Breast Cancer | unknown | Phase 2 | 80 | Harbin Medical UniversityOTHER | 1 | Jan 24, 2012 | clinicaltrials |
| NCT01292408 | Autophagy Inhibition Using Hydrochloroquine in Breast Cancer Patients | unknown | Phase 2 | 20 | Radboud University Medical CenterOTHER | 1 | Jan 20, 2012 | clinicaltrials |
| NCT01276769 | Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer | unknown | Phase 2 | 80 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 16, 2011 | clinicaltrials |
| NCT01451580 | Lipo-dox and Cyclophosphamide /5-Fluorouracil in Patients With Metastatic Breast Cancer | unknown | Phase 2 | 47 | TTY BiopharmINDUSTRY | 1 | Oct 13, 2011 | clinicaltrials |
| NCT01415336 | AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer | unknown | Phase 2 / Phase 3 | 300 | Peking Union Medical College HospitalOTHER | 1 | Aug 11, 2011 | clinicaltrials |
| NCT00927511 | A Study, Comparing a Dose-Titration Regimen of Fulvestrant With the Approved Dosing Regimen in Postmenopausal Patients With Hormone-Responsive Advanced Breast Cancer (ABC)(FIDeS) | unknown | Phase 2 | 104 | Regina Elena Cancer InstituteOTHER | 1 | Jul 22, 2011 | clinicaltrials |
| NCT01395706 | ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes | unknown | Phase 2 | 125 | Pulsion Medical Systems SEINDUSTRY | 1 | Jul 18, 2011 | clinicaltrials |
| NCT01053468 | Facilitating Physical Activity Behavior and Health Outcomes in Breast Cancer Patients Receiving Chemotherapy(PROACTIVE) | unknown | Phase 2 | 150 | Athabasca UniversityOTHER | 1 | Jul 1, 2011 | clinicaltrials |
| NCT00651417 | Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue | unknown | Phase 2 | 101 | Arizona Oncology ServicesOTHER | 1 | Jun 23, 2011 | clinicaltrials |
| NCT01199354 | Skin Sparing Mastectomy and Immediate Breast Reconstruction With Latissimus Dorsi Flap After Neoadjuvant Chemotherapy and Radiotherapy (M-RIC)(M-RIC) | unknown | Phase 2 | 80 | Clinique ClementvilleOTHER | 1 | Jun 9, 2011 | clinicaltrials |
| NCT01352494 | Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer(NeoTG) | unknown | Phase 2 | 99 | Korean Breast Cancer Study GroupOTHER | 1 | May 27, 2011 | clinicaltrials |
| NCT01351597 | A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer(STORM) | unknown | Phase 2 | 51 | Korean Breast Cancer Study GroupOTHER | 1 | May 11, 2011 | clinicaltrials |
| NCT00496288 | Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer | unknown | Phase 2 | 240 | Assaf-Harofeh Medical CenterOTHER_GOV | 1 | Apr 5, 2011 | clinicaltrials |
| NCT01321775 | Bevacizumab and Trastuzumab With Weekly Paclitaxel Followed, After Surgery, by Encapsuled Liposomal Doxorubicin, Cyclophosphamide and Trastuzumab as Adjuvant Treatment After Surgery on Women With Her2+ Breast Cancer | unknown | Phase 2 | 44 | Hospital Universitario Madrid SanchinarroOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00879489 | Cellular Immunotherapy Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 24 | Quantum Immunologics, Inc.OTHER | 1 | Feb 25, 2011 | clinicaltrials |
| NCT00930475 | Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 54 | Charite University, Berlin, GermanyOTHER | 1 | Jan 26, 2011 | clinicaltrials |
| NCT00398489 | Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery | unknown | Phase 2 | 94 | Technical University of MunichOTHER | 1 | Nov 9, 2010 | clinicaltrials |
| NCT00994968 | Doxorubicin Hydrochloride, Cyclophosphamide, Docetaxel, and S-1 Before Surgery in Treating Women With Stage II or Stage III Breast Cancer | unknown | Phase 2 | 49 | Yonsei UniversityOTHER | 1 | Oct 29, 2010 | clinicaltrials |
| NCT01196455 | Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer | unknown | Phase 2 | 39 | Croatian Cooperative Group for Clinical Research in OncologyOTHER | 1 | Sep 8, 2010 | clinicaltrials |
| NCT01195298 | Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer | unknown | Phase 2 | 88 | South Eastern European Research Oncology GroupOTHER | 1 | Sep 6, 2010 | clinicaltrials |
| NCT01175694 | Dose Optimization for Pulsed-dose-rate (PDR)/High-dose-rate (HDR) Brachytherapy Alone for Early Breast Cancer | unknown | Phase 2 | 200 | University Hospital ErlangenOTHER | 1 | Aug 20, 2010 | clinicaltrials |
| NCT01170143 | Efficacy and Safety Study of Trastuzumab, Paclitaxel and Carboplatin on HER2+ Preoperative Breast Cancer(PCH) | unknown | Phase 2 | 60 | Fudan UniversityOTHER | 1 | Jul 27, 2010 | clinicaltrials |
| NCT00178802 | Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers | unknown | Phase 2 | 24 | The University of Texas Health Science Center, HoustonOTHER | 1 | Apr 23, 2010 | clinicaltrials |
| NCT00948337 | A Study With Health Educational Material on Health Promotion in Cancer Survivors | unknown | Phase 2 | 326 | National Cancer Center, KoreaOTHER_GOV | 1 | Feb 26, 2010 | clinicaltrials |
| NCT00914017 | Statins and Breast Cancer Biomarkers | unknown | Phase 2 | 100 | University of VermontOTHER | 1 | Feb 11, 2010 | clinicaltrials |
| NCT00154882 | Paclitaxel (Phyxol) and Cisplatin as First-line Chemotherapy for Metastatic Breast Cancer | unknown | Phase 2 | 43 | National Taiwan University HospitalOTHER | 1 | Jan 21, 2010 | clinicaltrials |
| NCT00518583 | Phase II Study in Patients With Operable Breast Cancer | unknown | Phase 2 | 30 | Aptium Oncology Research NetworkNETWORK | 1 | Jan 15, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Mar 13, 2013source: clinicaltrials